Literature DB >> 11202141

Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study.

T Bschor1, B Müller-Oerlinghausen, G Ulrich.   

Abstract

About one third of manic patients show a decreased Electroencephalographic Vigilance Level (EVL). In two patients with recurrent manias the hypothesis was tested that the EEG may be used to predict the therapeutic response to methylphenidate. Patient A (with a decreased EVL) responded rapidly to methylphenidate with a considerable reduction of symptoms and a clear increase of EVL, whereas patient B (normal EVL) did not show any change, neither clinically nor in the EEG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11202141     DOI: 10.1177/155005940103200110

Source DB:  PubMed          Journal:  Clin Electroencephalogr        ISSN: 0009-9155


  4 in total

Review 1.  Use of Stimulants in Bipolar Disorder.

Authors:  Giulio Perugi; Giulia Vannucchi; Fulvio Bedani; Ettore Favaretto
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 2.  Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.

Authors:  Susanne Graef; Peter Schönknecht; Osama Sabri; Ulrich Hegerl
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

3.  [Manic behavior as an autoregulatory attempt to stabilize vigilance].

Authors:  U Hegerl; S Olbrich; P Schönknecht; C Sander
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

4.  Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.

Authors:  Michael Kluge; Ulrich Hegerl; Christian Sander; Jens Dietzel; Roland Mergl; Istvan Bitter; Koen Demyttenaere; Ricardo Gusmão; Ana Gonzalez-Pinto; Victor Perez-Sola; Eduard Vieta; Georg Juckel; Ulrich S Zimmermann; Michael Bauer; Pascal Sienaert; Sónia Quintão; Marc-Andreas Edel; Csilla Bolyos; Jose Luis Ayuso-Mateos; Pilar López-García
Journal:  BMC Psychiatry       Date:  2013-02-27       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.